During the past decade, Hospital Churruca conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hospital Churruca" are "Congestive Heart Failure" (1 trials), "Pancreatic Cancer" (1 trials), "Sudden Cardiac Arrest" (1 trials) and "Ventricular Arrythmia" (1 trials). Many other conditions were trialed in "Hospital Churruca" in a lesser frequency.

Most popular intervention types in "Hospital Churruca" are "Drug" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "ICD or CRT-D Device" (1 trials), "Tolvaptan" (1 trials), "erlotinib hydrochloride" (1 trials) and "gemcitabine hydrochloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Churruca" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Churruca". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hospital Churruca, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Churruca, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".